Sensydia develops a non-invasive Cardiac Performance System to rapidly assess hemodynamic function in heart failure and pulmonary hypertension patients, aiming to improve diagnostic and management outcomes.
Founded
2015
Total Funding
$10M+
Total Rounds
2
First Raise
May 9, 2023
Latest Raise
Oct 12, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/12/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free